SCHEMBL1932050

SCHEMBL1932050

[CH2]CC(=S)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16927157 0.94 FFAR3 (0.33)
SCHEMBL1932036 0.82
SCHEMBL4019230 0.79
SCHEMBL16927168 0.79
SCHEMBL1931623 0.79
SCHEMBL6255596 0.78 CES2 (0.44)
SCHEMBL6256424 0.78 CES2 (0.44)
SCHEMBL6260023 0.78 CES2 (0.44)
SCHEMBL16927162 0.77
SCHEMBL4417296 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115175967-B Ionic liquids for stabilizing viscosity of silicate-based coatings 巴斯夫欧洲公司 2024-06-14 CN disclosed
US-20230042328-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2023-02-09 US disclosed
CN-115175967-A Ionic liquids for stabilizing viscosity of silicate-based coatings 巴斯夫欧洲公司 2022-10-11 CN disclosed
CN-111808658-B Lubricating oil composition JXTG能源株式会社 2022-08-12 CN disclosed
US-11266648-B2 Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors ImmuneTarget, Inc. (US) 2022-03-08 US disclosed
WO-2022026339-A1 METHODS OF TREATING AUTOIMMUNE DISEASES WITH SMALL MOLECULE NF-KB INHIBITORS ImmuneTarget, Inc. (US) 2022-02-03 WO disclosed
US-20220023301-A1 METHODS OF TREATING AUTOIMMUNE DISEASES WITH SMALL MOLECULE NF-kB INHIBITORS ImmuneTarget, Inc. (US) 2022-01-27 US disclosed
US-11083729-B2 Methods of treating cancer with small molecule NF-κB inhibitors ImmuneTarget, Inc. (US) 2021-08-10 US disclosed
WO-2021122673-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2021-06-24 WO disclosed
US-20200345739-A1 SMALL MOLECULE NF-kB INHIBITORS ImmuneTarget, Inc. 2020-11-05 US disclosed
WO-2010072696-A2 MIXTURES OF HYDROPHOBIC AND HYDROPHILIC IONIC LIQUIDS AND USE THEREOF IN LIQUID RING COMPRESSORS BASF SE (DE) 2010-07-01 WO disclosed
US-20100112646-A1 ENZYMATIC HYDROLYSIS OF A CELLULOSE MATERIAL TREATED WITH AN IONIC LIQUID BASF SE (DE) 2010-05-06 US disclosed
US-20100081798-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION BASF SE (DE) 2010-04-01 US disclosed
EP-2126104-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION BASF SE (DE) 2009-12-02 EP disclosed
EP-2111459-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT CAN BE PRETREATED WITH AN IONIC LIQUID CONTAINING A POLYATOMIC ANION BASF SE (DE) 2009-10-28 EP disclosed
WO-2009087184-A1 PROCESS FOR WORKING UP IONIC LIQUIDS BASF SE (DE) 2009-07-16 WO disclosed
WO-2009077452-A1 METHOD FOR IMPROVING THE HYDROLYSIS STABILITY OF IONIC LIQUIDS BASF SE (DE) 2009-06-25 WO disclosed
WO-2008119770-A1 METHOD FOR MODIFYING THE STRUCTURE OF A CELLULOSE MATERIAL BY TREATMENT WITH AN IONIC LIQUID BASF SE (DE) 2008-10-09 WO disclosed
WO-2008090156-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION BASF SE (DE) 2008-07-31 WO disclosed
WO-2008090155-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT CAN BE PRETREATED WITH AN IONIC LIQUID CONTAINING A POLYATOMIC ANION BASF SE (DE) 2008-07-31 WO disclosed